Benjamin F. Edwards & Company’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3K | Hold |
152
| – | – | ﹤0.01% | 1970 |
|
|
2024
Q1 | $3K | Sell |
152
-155
| -50% | -$3K | ﹤0.01% | 1942 |
|
|
2023
Q4 | $7K | Buy |
307
+167
| +119% | +$3.45K | ﹤0.01% | 1743 |
|
|
2023
Q3 | $3K | Sell |
140
-3
| -2% | -$68 | ﹤0.01% | 1622 |
|
|
2023
Q2 | $4K | Buy |
143
+3
| +2% | +$79 | ﹤0.01% | 1579 |
|
|
2023
Q1 | $4K | Hold |
140
| – | – | ﹤0.01% | 1575 |
|
|
2022
Q4 | $4K | Hold |
140
| – | – | ﹤0.01% | 1603 |
|
|
2022
Q3 | $3K | Hold |
140
| – | – | ﹤0.01% | 1631 |
|
|
2022
Q2 | $4K | Hold |
140
| – | – | ﹤0.01% | 1566 |
|
|
2022
Q1 | $5K | Hold |
140
| – | – | ﹤0.01% | 1503 |
|
|
2021
Q4 | $5K | Hold |
140
| – | – | ﹤0.01% | 1505 |
|
|
2021
Q3 | $4K | Hold |
140
| – | – | ﹤0.01% | 1550 |
|
|
2021
Q2 | $5K | Sell |
140
-301
| -68% | -$12.4K | ﹤0.01% | 1499 |
|
|
2021
Q1 | $19K | Buy |
441
+301
| +215% | +$14.1K | ﹤0.01% | 1214 |
|
|
2020
Q4 | $6K | Hold |
140
| – | – | ﹤0.01% | 1355 |
|
|
2020
Q3 | $5K | Hold |
140
| – | – | ﹤0.01% | 1406 |
|
|
2020
Q2 | $4K | Hold |
140
| – | – | ﹤0.01% | 1462 |
|
|
2020
Q1 | $4K | Sell |
140
-25
| -15% | -$747 | ﹤0.01% | 1453 |
|
|
2019
Q4 | $6K | Sell |
165
-57
| -26% | -$2.06K | ﹤0.01% | 1536 |
|
|
2019
Q3 | $8K | Hold |
222
| – | – | ﹤0.01% | 1460 |
|
|
2019
Q2 | $10K | Hold |
222
| – | – | ﹤0.01% | 1403 |
|
|
2019
Q1 | $9K | Hold |
222
| – | – | ﹤0.01% | 1337 |
|
|
2018
Q4 | $10K | Buy |
222
+58
| +35% | +$3.04K | ﹤0.01% | 1275 |
|
|
2018
Q3 | $11K | Hold |
164
| – | – | ﹤0.01% | 1243 |
|
|
2018
Q2 | $9K | Sell |
164
-12
| -7% | -$634 | ﹤0.01% | 1288 |
|
|
2018
Q1 | $8K | Sell |
176
-25
| -12% | -$1.19K | ﹤0.01% | 1304 |
|
|
2017
Q4 | $9K | Hold |
201
| – | – | ﹤0.01% | 1220 |
|
|
2017
Q3 | $9K | Hold |
201
| – | – | ﹤0.01% | 1177 |
|
|
2017
Q2 | $8K | Sell |
201
-8
| -4% | -$302 | ﹤0.01% | 1135 |
|
|
2017
Q1 | $8K | Sell |
209
-6
| -3% | -$234 | ﹤0.01% | 1065 |
|
|
2016
Q4 | $8K | Hold |
215
| – | – | ﹤0.01% | 981 |
|
|
2016
Q3 | $7K | Buy |
215
+8
| +4% | +$280 | ﹤0.01% | 898 |
|
|
2016
Q2 | $7K | Hold |
207
| – | – | ﹤0.01% | 854 |
|
|
2016
Q1 | $6K | Sell |
207
-16
| -7% | -$426 | ﹤0.01% | 882 |
|
|
2015
Q4 | $7K | Sell |
223
-8
| -3% | -$249 | ﹤0.01% | 904 |
|
|
2015
Q3 | $7K | Sell |
231
-19
| -8% | -$663 | ﹤0.01% | 934 |
|
|
2015
Q2 | $10K | Buy |
250
+120
| +92% | +$5.39K | ﹤0.01% | 921 |
|
|
2015
Q1 | $6K | Sell |
130
-11
| -8% | -$510 | ﹤0.01% | 969 |
|
|
2014
Q4 | $6K | Buy |
+141
| New | +$5.54K | ﹤0.01% | 863 |
|
Other funds holding AVNS
RC
WHG
PIM
Benjamin F. Edwards & Company's AVNS Position: Q2 2024 in Review
Benjamin F. Edwards & Company held its Avanos Medical (AVNS) position steady in Q2 2024 at 152 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1970.
Benjamin F. Edwards & Company first reported a position in AVNS in Q4 2014 and has held it in 39 quarters since. The position peaked at $19K in Q1 2021. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.
- Benjamin F. Edwards & Company held 152 shares of Avanos Medical worth $3K as of Q2 2024.
- Benjamin F. Edwards & Company left its Avanos Medical share count unchanged in Q2 2024.
- Avanos Medical made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1970 holding.
- Benjamin F. Edwards & Company first reported a position in Avanos Medical in Q4 2014 and has held it in 39 quarters since.
- Benjamin F. Edwards & Company's Avanos Medical position peaked at $19K in Q1 2021.
- 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.